0

512600

ASTALLTD

img img img img
No Data Available

ASTAL LABORATORIES LIMITED Share Price Update

As of the latest trading session, ASTAL LABORATORIES LIMITED is trading at ₹89.05, up by ₹14.84 or 19.99% from its previous close. The stock has moved between ₹78.00 and ₹89.05 today. Over the past year, the stock has delivered a return of 7.81%. In the last month, it has returned 23.23%.

Investment Returns

Over 1 Month 23.23% Over 3 Months 10.96% Over 6 Months -6.55% Over 1 Year 7.81%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ASTAL LABORATORIES LIMITED fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 375.00
  • P/E Ratio (TTM) 38.29
  • Beta 0.31
  • Book Value / share 76.88
  • Return on equity 30.10%
  • EPS (TTM) 2.32
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 2.36
info icon alternate text

ASTAL LABORATORIES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 52.24
Operating Expense 49.14
Net Profit 2.36
Net Profit Margin (%) 4.51
Earnings Per Share (EPS) 2.19
EBITDA 3.58
Effective Tax Rate (%) 24.60
Particulars SEP 2025 (Values in Cr)
Revenue 37.52
Operating Expense 34.08
Net Profit 2.58
Net Profit Margin (%) 6.87
Earnings Per Share (EPS) 2.40
EBITDA 3.90
Effective Tax Rate (%) 25.64
Particulars JUN 2025 (Values in Cr)
Revenue 25.33
Operating Expense 22.59
Net Profit 2.09
Net Profit Margin (%) 8.25
Earnings Per Share (EPS) 2.13
EBITDA 3.21
Effective Tax Rate (%) 25.08
Particulars MAR 2025 (Values in Cr)
Revenue 23.47
Operating Expense 19.66
Net Profit 2.74
Net Profit Margin (%) 11.67
Earnings Per Share (EPS) 2.80
EBITDA 4.22
Effective Tax Rate (%) 28.57
Particulars DEC 2024 (Values in Cr)
Revenue 14.46
Operating Expense 11.50
Net Profit 2.49
Net Profit Margin (%) 17.21
Earnings Per Share (EPS) 2.53
EBITDA 3.38
Effective Tax Rate (%) 17.54
Particulars MAR 2025 (Values in Cr)
Revenue 64.23
Operating Expense 52.38
Net Profit 8.93
Net Profit Margin (%) 13.90
Earnings Per Share (EPS) 9.08
EBITDA 12.90
Effective Tax Rate (%) 25.45
Particulars MAR 2024 (Values in Cr)
Revenue 23.65
Operating Expense 22.57
Net Profit 0.78
Net Profit Margin (%) 3.29
Earnings Per Share (EPS) 0.80
EBITDA 1.13
Effective Tax Rate (%) 27.52
Particulars MAR 2023 (Values in Cr)
Revenue 3.43
Operating Expense 3.57
Net Profit 0.02
Net Profit Margin (%) 0.58
Earnings Per Share (EPS) 0.04
EBITDA 0.04
Effective Tax Rate (%) 66.66
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.23
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.04
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.20
Net Profit 0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.02
EBITDA 0.03
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 32.77
ROE % 30.10
ROCE % 34.78
Total Debt to Total Equity 0.23
EBITDA Margin 20.08
Particulars MAR 2024 (Values in Cr)
Book Value / Share 23.71
ROE % 5.47
ROCE % 7.56
Total Debt to Total Equity 0.01
EBITDA Margin 4.78
Particulars MAR 2023 (Values in Cr)
Book Value / Share 12.98
ROE % 0.39
ROCE % 0.77
Total Debt to Total Equity 0.00
EBITDA Margin 1.17
Particulars MAR 2022 (Values in Cr)
Book Value / Share 12.93
ROE % -0.39
ROCE % -0.19
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 12.97
ROE % 0.19
ROCE % 0.19
Total Debt to Total Equity 0.00
EBITDA Margin 10.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.73
Total Assets 63.34
Total Liabilities 63.34
Total Equity 35.99
Share Outstanding 0
Price to Book Ratio 2.32
Return on Assets (%) 14.09
Return on Capital (%) 18.12
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.07
Total Assets 36.61
Total Liabilities 36.61
Total Equity 23.33
Share Outstanding 0
Price to Book Ratio 1.72
Return on Assets (%) 2.14
Return on Capital (%) 3.32
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 9.90
Total Liabilities 9.90
Total Equity 5.17
Share Outstanding 0
Price to Book Ratio 2.28
Return on Assets (%) 0.16
Return on Capital (%) 0.32
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 5.22
Total Liabilities 5.22
Total Equity 5.16
Share Outstanding 0
Price to Book Ratio 1.25
Return on Assets (%) -0.32
Return on Capital (%) -0.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 5.30
Total Liabilities 5.30
Total Equity 5.17
Share Outstanding 0
Price to Book Ratio 0.67
Return on Assets (%) 0.11
Return on Capital (%) 0.12
Particulars MAR 2025 (Values in Cr)
Net Income 11.97
Cash from Operations -12.21
Cash from Investing -7.81
Cash from Financing 3.29
Net change in Cash -17.04
Free Cash Flow -6.44
Particulars MAR 2024 (Values in Cr)
Net Income 1.08
Cash from Operations -5.54
Cash from Investing -6.10
Cash from Financing 17.67
Net change in Cash 5.99
Free Cash Flow 0.36
Particulars MAR 2023 (Values in Cr)
Net Income 0.03
Cash from Operations -1.42
Cash from Investing 1.50
Cash from Financing 0.00
Net change in Cash 0.06
Free Cash Flow -1.42
Particulars MAR 2022 (Values in Cr)
Net Income -0.01
Cash from Operations -0.24
Cash from Investing 0.23
Cash from Financing 0.00
Net change in Cash -0.01
Free Cash Flow -0.24
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations -0.18
Cash from Investing 0.20
Cash from Financing 0.00
Net change in Cash 0.01
Free Cash Flow -0.18
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 33.09 14.32 1.71 253.58 23.12 40.44
BLISS GVS PHARMA LTD. 269.35 25.75 2.51 2849.43 105.05 280.20
CIPLA LTD 1347.70 22.90 3.30 108864.87 1165.55 1672.20
FERMENTA BIOTECH LTD. 288.70 9.60 2.17 849.67 252.15 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2484.70 41.85 24.64 42092.32 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 33.09 31.82 4.61 253.58 23.12 40.44
AMRUTANJAN HEALTH CARE LTD. 548.80 27.44 4.63 1586.62 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8489.25 102.02 26.56 21223.13 7630.00 10653.05
BLISS GVS PHARMA LTD. 269.35 36.70 2.58 2849.43 105.05 280.20

ASTAL LABORATORIES LIMITED shareholding pattern

Holding
95.29%
4.7%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

ASTAL LABORATORIES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
88.84 19.71 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 73.80
  • 26 Days 68.30
  • 10 Days 69.50
  • 50 Days 70.70
  • 12 Days 68.90
  • 100 Days 75.20
  • 20 Days 68.10
  • 200 Days 79.40
71.06 PIVOT
First Support 66.40 First Resistance 78.87 Second Support 58.59 Second Resistance 83.53 Third Support 53.93 Third Resistance 91.34
RSI 77.91 ADX 17.17 MACD 0.52 Williams % R -0.73 Commodity Channel Index (CCI) 320.81
Date 2026-05-08 Week 29345.00 Same Day 85027.00 Month 28941.00
1 Year 0.31 3 Year 0.25
Over 1 Month
23.23% down
Over 1 Year
7.81% down
Over 3 Months
10.96% down
Over 3 Years
39.65% down
Over 6 Months
-6.55% down
Over 5 Years
58.97% down

ASTAL LABORATORIES LIMITED Corporate Actions

Top Gainers

Top Losers

ASTAL LABORATORIES LIMITED Share Price

Astal Laboratories Limited was formerly incorporated as a public company limited by shares on August 03, 1993 in the name of Macro International Limited. The Company was taken over under SEBI takeover guidelines in 2022 and the main objects of the Company was changed to 'Manufacture and Sales of Pharmaceutical Intermediates and Bulk Drugs'. Subsequently the name of the Company was changed to Astal Laboratories Limited in May, 2024. The Company is now a subsidiary of Aceso Research Labs LLP.

The Company was promoted by the Kanpur based business house of Parasrampurias. The Company set up a departmental store at Plaza Kalpana, Birhana Road, Kanpur, offering products such as readymade garments, electronic items, leather items, stationery, books, fast food centre etc.

During 1996-97, the departmental store project succeeded, only Saree Division and Archies Card Division was in operation. The Leather Unit set up at Village Goddhroli, Distt. Fatehpur manufactured of various leather harness and sadddlery goods viz., bridles, halters, girths, martingles, stirup leather, leather reins, brow bands and saddles.

Company has ventured into the pharmaceutical bulk drug business and Key Starting Materials/ Intermediates in FY2025 to meet the growing global demand for essential pharmaceutical ingredients.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Astal Laboratories Ltd?

Answer Field

Astal Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 88.84 as on May 08 2026 03:28 PM.

What is the Market Cap of Astal Laboratories Ltd Share?

Answer Field

The market cap of Astal Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 375.00 as on May 08 2026 03:28 PM.

What is the 52 Week High and Low of Astal Laboratories Ltd?

Answer Field

The 52 Week High and Low of Astal Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 103.20 and ₹ 60.45.

What is 1 year return for Astal Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 7.81%.

What is the P/E Ratio of Astal Laboratories Ltd Share?

Answer Field

As on May 08 2026 03:28 PM the price-to-earnings (PE) ratio for Astal Laboratories Ltd share is 38.29.

What is the PB ratio of Astal Laboratories Ltd Share?

Answer Field

As on May 08 2026 03:28 PM, the price-to-book (PB) ratio for Astal Laboratories Ltd share is 76.88.

How to Buy Astal Laboratories Ltd Share?

Answer Field

You can trade in Astal Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Astal Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Astal Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Astal Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|